Jiuzhou Pharmaceutical announced that the company previously planned to use 200 million yuan to 400 million yuan to repurchase shares, with a maximum repurchase price of 19.9 yuan/share. The shares will be used to reduce registered capital and employee shareholding plans or equity incentives. The company has completed the repurchase. The actual repurchase of 154.12,800 shares, accounting for 1.75% of the total share capital. The transaction price range is 12.12 yuan/share to 16.07 yuan/share, with a payment of 212 million yuan; of these, 6.1651 million shares will be cancelled on September 30, 2026, and the remaining 9.247,700 shares will be used for employee stock ownership plans or equity incentives.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.